S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
Shift in war's front seen as grain leaves Ukraine; plant hit
NYSE:NVO

Novo Nordisk A/S (NVO) News Headlines

$103.20
-1.27 (-1.22%)
(As of 08/5/2022 08:49 PM ET)
Add
Compare
Today's Range
$102.12
$104.26
50-Day Range
$99.91
$116.93
52-Week Range
$91.51
$122.16
Volume
2.59 million shs
Average Volume
1.51 million shs
Market Capitalization
$233.54 billion
P/E Ratio
30.81
Dividend Yield
1.43%
Price Target
$682.43
Get Novo Nordisk A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter.

NVO Media Mentions By Week

NVO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NVO
News Sentiment

0.29

0.33

Average
Medical
News Sentiment

NVO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NVO Articles
This Week

20

4

NVO Articles
Average Week



SourceHeadline
marketbeat.com logoQ3 2022 EPS Estimates for Novo Nordisk A/S (NYSE:NVO) Cut by Analyst
marketbeat.com - August 8 at 1:52 AM
marketbeat.com logoNovo Nordisk A/S (NYSE:NVO) Plans Semi-annual Dividend of $0.58
marketbeat.com - August 5 at 4:56 PM
finance.yahoo.com logoQuest to Cut Prescription Drug Prices Puts Insulin in Spotlight
finance.yahoo.com - August 5 at 9:09 PM
seekingalpha.com logoNovo Nordisk rebounds as company addresses concerns over obesity drug supply
seekingalpha.com - August 4 at 2:11 PM
finance.yahoo.com logoNovo Nordisk (NVO) Q2 2022 Earnings Call Transcript
finance.yahoo.com - August 4 at 2:11 PM
finance.yahoo.com logoNovo Nordisk's (NVO) Q2 Earnings Miss, Sales Beat Estimates
finance.yahoo.com - August 4 at 2:11 PM
finance.yahoo.com logoObesity drug supply delay not unusual says Novo Nordisk CEO
finance.yahoo.com - August 4 at 8:54 AM
marketwatch.com logoNovo Nordisk Lifts Guidance After 2Q Net Profit Rose -- Earnings Review
marketwatch.com - August 4 at 3:53 AM
nasdaq.com logoNovo Nordisk H1 Profit Increases; Raises Full Year Outlook
nasdaq.com - August 4 at 3:53 AM
seekingalpha.com logoNovo Nordisk falls despite guidance boost on strong 1H
seekingalpha.com - August 3 at 10:47 PM
seekingalpha.com logoNovo Nordisk A/S (NVO) CEO Lars Fruergaard Joergensen on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 3 at 10:47 PM
nasdaq.com logoOversold Conditions For Novo-Nordisk (NVO)
nasdaq.com - August 3 at 5:47 PM
nasdaq.com logoNovo Nordisk raises 2022 outlook after strong first half
nasdaq.com - August 3 at 12:47 PM
msn.com logoHere's How Much $100 Invested In Novo Nordisk 10 Years Ago Would Be Worth Today
msn.com - August 3 at 12:47 PM
finance.yahoo.com logoDrug, Biotech Stocks' Q2 Earnings on Aug 4: LLY, AMGN & More
finance.yahoo.com - August 3 at 12:47 PM
finance.yahoo.com logoNovo Nordisk's sales increased by 25% in Danish kroner and by 16% at constant exchange rates to DKK 83.3 billion in the first six months of 2022
finance.yahoo.com - August 3 at 12:47 PM
finance.yahoo.com logoNovo Nordisk shares fall on Wegovy news despite outlook lift
finance.yahoo.com - August 3 at 12:47 PM
finance.yahoo.com logoNovo Nordisk's Obesity Sales Nearly Doubled, But That Wasn't Enough For NVO Stock
finance.yahoo.com - August 3 at 12:47 PM
msn.com logoNovo Nordisk Earnings Conference Call Is Coming Up, Here's What You Need To Know
msn.com - August 1 at 2:59 PM
finance.yahoo.com logoNovo Nordisk Once-Weekly Insulin Hits Primary Goals In In Two Phase 3 Trials
finance.yahoo.com - July 29 at 6:12 PM
finance.yahoo.com logoNovo Nordisk achieves primary objectives of ONWARDS 3 and 4 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin degludec in ONWARDS 3
finance.yahoo.com - July 29 at 1:11 PM
MarketBeat logoBrokerages Set Novo Nordisk A/S (NYSE:NVO) PT at $697.50
americanbankingnews.com - July 26 at 2:16 AM
finance.yahoo.com logoHere’s What Makes Novo Nordisk (NVO) an Interesting Investment Option
finance.yahoo.com - July 23 at 1:38 PM
finance.yahoo.com logo2 Pharma Giants With Momentum That Could Carry Through 2030
finance.yahoo.com - July 22 at 1:49 PM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights AMN Healthcare, Boeing, Clorox, Novo Nordisk and Costco Wholesale
finance.yahoo.com - July 19 at 9:44 AM
MarketBeat logoNovo Nordisk A/S (NYSE:NVO) Upgraded at Morgan Stanley
americanbankingnews.com - July 19 at 2:34 AM
benzinga.com logo$100 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today
benzinga.com - July 15 at 10:49 PM
finance.yahoo.com logoA new ‘miracle’ weight-loss drug really works — raising huge questions
finance.yahoo.com - July 14 at 11:29 AM
finance.yahoo.com logoMarinus to sell rare-disease voucher to Novo Nordisk for $110 million
finance.yahoo.com - July 14 at 11:29 AM
seekingalpha.com logoUpdating On Novo Nordisk: Still Overvalued
seekingalpha.com - July 13 at 2:38 AM
seekingalpha.com logoNovo Nordisk: EPS Growth With Impressive Relative Strength
seekingalpha.com - July 12 at 4:06 PM
finance.yahoo.com logoIBD Screen Of The Day: Mutual Funds Are Buying These Energy Stocks
finance.yahoo.com - July 12 at 10:06 AM
finance.yahoo.com logoNovo Nordisk's Mim8 Shows Potential As Once Monthly Treatment For Hemophilia A
finance.yahoo.com - July 11 at 6:56 PM
nasdaq.com logoNovo Nordisk :phase 3 Data For Concizumab Show 86% Reduction In Treated Bleeds In Haemophilia A Or B
nasdaq.com - July 11 at 2:34 AM
finance.yahoo.com logoNovo Nordisk A/S: Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitors
finance.yahoo.com - July 10 at 4:33 PM
finance.yahoo.com logoChinook (KDNY) Stock Rallies 24.2% in 3 Months: Here's Why
finance.yahoo.com - July 8 at 3:36 PM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights Novo Nordisk, Intel, Qualcomm, T-Mobile US and Sony Group
finance.yahoo.com - July 6 at 10:15 AM
finance.yahoo.com logo2 Safe Stocks That Can Survive Any Downturn
finance.yahoo.com - July 2 at 6:10 PM
benzinga.com logoHere's How Much $1000 Invested In Novo Nordisk 5 Years Ago Would Be Worth Today
benzinga.com - June 30 at 9:57 PM
finance.yahoo.com logoIllumina's (ILMN) GRAIL to Offer Galleri Test in Indianapolis
finance.yahoo.com - June 29 at 3:54 PM
finance.yahoo.com logoOmnicell (OMCL) Up 10% Since Q1 Earnings: What's Driving It?
finance.yahoo.com - June 29 at 3:54 PM
seekingalpha.com logoSanofi to cut out-of-pocket insulin costs to $35 for uninsured Americans
seekingalpha.com - June 29 at 10:13 AM
onmsft.com logoMicrosoft highlights how HoloLens 2 helps pharmaceutical giant, Novo Nordisk
onmsft.com - June 27 at 5:01 PM
seekingalpha.com logoNovo Nordisk, Echosens team up to advance early diagnosis, awareness for liver disease
seekingalpha.com - June 23 at 8:52 AM
finance.yahoo.com logoCamp Huronda welcomes back campers for a long-awaited reopening and unveils the new Insul-Inn
finance.yahoo.com - June 23 at 8:52 AM
finance.yahoo.com logoEchosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
finance.yahoo.com - June 22 at 8:38 AM
seekingalpha.com logoBlackRock lowers stake in Novo Nordisk
seekingalpha.com - June 16 at 8:56 AM
finance.yahoo.com logoIs Novo Nordisk (NVO) a Smart Long-Term Investment?
finance.yahoo.com - June 15 at 9:54 AM
finance.yahoo.com logoNovo Nordisk A/S: Our New Capsule System Tackles Biopharma ESG Risk Tied to U.S. Drug Pricing and Cost-Effectiveness
finance.yahoo.com - June 14 at 8:34 PM
seekingalpha.com logoNovo Nordisk A/S (NVO) Presents at ADA 82nd Scientific Sessions (Transcript)
seekingalpha.com - June 6 at 1:40 PM
nasdaq.com logoNovo Nordisk: Main Phases Of ONWARDS 1, ONWARDS 6 Phase 3a Trials Achieve Primary Objectives
nasdaq.com - June 3 at 10:42 AM
finance.yahoo.com logoNovo Nordisk achieves primary objectives of ONWARDS 1 and 6 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin glargine U100 in ONWARDS 1
finance.yahoo.com - June 3 at 4:29 AM
Get Novo Nordisk A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter.

This page (NYSE:NVO) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.